Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 49.20
-1.30 (-2.57%)
Oct 15, 2026, 3:58 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 830.98 million as of October 15, 2026. It is the 26,469th most valuable company in the world and the 328th biggest in Sweden. Its market cap has decreased by 63.47% in one year.
Market Cap
830.98M
Enterprise Value
795.78M
Revenue
250.30M
Global Rank
Country Rank
#328 Sweden
PE Ratio
55.58
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 830.98M, a decrease of -38.53%. That is a compound annual growth rate of -9.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 830.98M | -56.31% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BICO Group AB | 1.75B |
| Paxman AB | 1.50B |
| C-Rad AB | 979.24M |
| Sedana Medical AB | 938.73M |
| Episurf Medical AB | 663.75M |
| Bactiguard Holding AB | 527.41M |
| BrainCool AB | 447.79M |
| Senzime AB | 440.99M |